Delivery Order SPE2DR25D1022-SPE2DR26FRC4D
Award Date 4/23/26
Potential Completion Date 4/24/26
Potential Value $15K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $12,912.82 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for VEMLIDY 25 mg tablets (30-count unit dose), with an ultimate completion date of April 20, 2026. The order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to military healthcare systems.</p> <p>Place of performance is Conshohocken, PA. This is a firm fixed-price delivery order with no set-aside applied.</p>
- The Defense Logistics Agency issued a $5,439.10 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for VEMLIDY 25 mg tablets (30-count units) with an ultimate completion date of March 10, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $7,326.24 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for VEMLIDY 25 mg tablets (30-count units), with a completion date of March 24, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that enables supply of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a $3,174.42 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for VEMLIDY 25 mg tablets (30-count unit dose). The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 7, 2026. Pricing is firm fixed price with...
- The Defense Logistics Agency issued a $5,059.28 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for VEMLIDY 25 mg tablets (30-count units). Ultimate completion date is March 13, 2026. Place of performance is Conshohocken, PA. The order is issued under a firm fixed-price pricing structure with no set-aside. This delivery order is a call against Amerisourcebergen Drug Corp's parent IDC with DLA Troop Support Medical, a $999,999,999.00 indefinite delivery contract running through...
- The Defense Logistics Agency issued a $9,207.28 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for VEMLIDY 25 mg tablets (30-count units), with an ultimate completion date of March 13, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This vehicle supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $7,396.08 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for VEMLIDY 25 mg tablets (30-count unit dose). The order is placed under Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries firm fixed...
- The Defense Logistics Agency issued a $7,675.36 delivery order to AmerisourceBergen Drug Corp on March 23, 2026, for VEMLIDY 25 MG tablets (30-count units), firm fixed price, with an ultimate completion date of March 24, 2026. Place of performance is Conshohocken, PA. The order was issued under the DLA Troop Support Medical indefinite delivery contract with a ceiling value of $999,999,999.00 running through December 2026, which provides pharmaceutical and medical supply distribution globally...
- The Defense Logistics Agency issued a $3,126.96 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for VEMLIDY 25 mg tablets (30-count unit of use packaging). The order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supports pharmaceutical supply globally to military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price...
- The Defense Logistics Agency issued a $3,302.59 delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for VEMLIDY 25 mg tablets (30-count unit of use packaging). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FRC4DDelivery Order
The Defense Logistics Agency issued a $15,140.28 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for VEMLIDY 25 mg tablets (30-count unit of use packaging). Ultimate completion is April 24, 2026. Place of performance is Conshohocken, PA. The order is priced as firm fixed price with no set-aside applied. This represents a transactional pharmaceutical delivery under the DLA Troop Support Medical indefinite delivery contract vehicle, reflecting the company's role as a standing pharmaceutical prime vendor to Defense Health Agency and military medical facilities.
Generated 7/22/26, 11:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 4/22/26 |